13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001527166
Total reported value
$10.0B
$10.0B
32 檔
13.2%
In Q1 2024, Carlyle Group Inc.'s U.S. equity holdings reached a combined market value of $10.0B, distributed across 32 disclosed stock positions.
In Q1 2024, Carlyle Group Inc. displayed an active expansion posture, initiating 10 new positions and adding to 3 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including QDEL, GTM, SLNOEUR) accounted for 13.2% of total reported equity market value during Q1 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | QDEL | Quidelortho CORP | Stock-Other | 37.66% | — | — | |
| 2 | GTM | Zoominfo Technologies Inc | Stock-Tech | 26.52% | — | -25.54% | |
| 3 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 10.91% | — | +42.47% | |
| 4 | ✓ | Vitru LTD | Stock-Other | 5.93% | — | — | |
| 5 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 2.49% | — | — | |
| 6 | GETY | Getty Images Holdings Inc | Stock-Other | 2.41% | — | -1.93% | |
| 7 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 2.34% | +0.01% | — | |
| 8 | JSPR | Jasper Therapeutics Inc | Stock-Other | 1.97% | -0.01% | — | |
| 9 | ✓ | Hillevax Inc | Stock-Other | 1.92% | — | — | |
| 10 | GDS | Gds Holdings LTD - Adr | Stock-Other | 1.71% | — | — | |
| 11 | SMHI | Seacor Marine Holdings Inc | Stock-Other | 1.15% | — | — | |
| 12 | QTTB | Q32 Bio Inc | Stock-Other | 1.14% | -0.06% | — | |
| 13 | INVH | Invitation Homes Inc | Stock-Real Estate | 1.07% | +0.04% | — | |
| 14 | CUBE | Cubesmart | Stock-Real Estate | 0.63% | -0.08% | EXIT | |
| 15 | TORCEUR | Adicet Bio Inc | Stock-Other | 0.43% | — | +39.39% | |
| 16 | DNUT | Krispy Kreme Inc | Stock-Other | 0.33% | — | — | |
| 17 | ✓ | Reneo Pharmaceuticals Inc | Stock-Other | 0.28% | — | — | |
| 18 | EM | Smart Share Global LTD - Adr | Stock-Other | 0.20% | — | — | |
| 19 | EFTR | Effector Therapeutics Inc | Stock-Other | 0.17% | — | — | |
| 20 | SPWR | Sunpower Inc | Stock-Other | 0.17% | +0.01% | +79.78% | |
| 21 | SPRU | Spruce Power Holding Corporation | Stock-Other | 0.14% | — | — | |
| 22 | NABL | N-able Inc | Stock-Other | 0.08% | — | — | |
| 23 | 0OIA | Solarwinds CORP | Stock-Other | 0.07% | — | — | |
| 24 | AVGO | Broadcom Inc | Stock-Tech | 0.06% | — | — | |
| 25 | NU | Nu Holdings Ltd. | Stock-Financials | 0.05% | — | — | |
| 26 | ✓ | Nucana PLC Sponsored Adr | Stock-Other | 0.05% | — | — | |
| 27 | DASH | Doordash Inc - A | Stock-Consumer Disc | 0.04% | — | — | |
| 28 | SYRE | Spyre Therapeutics Inc | Stock-Other | 0.02% | — | EXIT | |
| 29 | ✓ | Stock-Other | 0.02% | — | — | ||
| 30 | 8QR | Confluent Inc-class A | Stock-Other | 0.01% | — | — | |
| 31 | XCUREUR | Exicure Inc | Stock-Other | 0.01% | — | — | |
| 32 | MTEMEUR | Molecular Templates Inc | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SLNOEUR | Soleno Therapeutics Inc | +5.4% | +42.47% | Add |
| 2 | JSPR | Jasper Therapeutics Inc | +2% | NEW | New buy |
| 3 | ✓ | Vitru LTD | +1.2% | — | Unchanged |
| 4 | QTTB | Q32 Bio Inc | +1.1% | NEW | New buy |
| 5 | PHAT | Phathom Pharmaceuticals Inc | +0.8% | — | Unchanged |
| 6 | ✓ | Hillevax Inc | +0.5% | — | Unchanged |
| 7 | SMHI | Seacor Marine Holdings Inc | +0.4% | — | Unchanged |
| 8 | DNUT | Krispy Kreme Inc | +0.3% | NEW | New buy |
| 9 | INVH | Invitation Homes Inc | +0.3% | — | Unchanged |
| 10 | TORCEUR | Adicet Bio Inc | +0.3% | +39.39% | Add |
| 11 | EFTR | Effector Therapeutics Inc | +0.2% | NEW | New buy |
| 12 | VRNA | Verona Pharma PLC - Adr | +0.1% | — | Unchanged |
| 13 | CUBE | Cubesmart | +0.1% | — | Unchanged |
| 14 | NABL | N-able Inc | +0.1% | NEW | New buy |
| 15 | EM | Smart Share Global LTD - Adr | +0.1% | — | Unchanged |
| 16 | 0OIA | Solarwinds CORP | +0.1% | NEW | New buy |
| 17 | ✓ | Reneo Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 18 | AVGO | Broadcom Inc | +0.1% | NEW | New buy |
| 19 | NU | Nu Holdings Ltd. | +0.1% | NEW | New buy |
| 20 | GETY | Getty Images Holdings Inc | 0% | -1.93% | Trim |
| 21 | DASH | Doordash Inc - A | 0% | NEW | New buy |
| 22 | 8QR | Confluent Inc-class A | 0% | NEW | New buy |
| 23 | SYRE | Spyre Therapeutics Inc | 0% | — | Unchanged |
| 24 | ✓ | 0% | — | Unchanged | |
| 25 | ✓ | Nucana PLC Sponsored Adr | — | — | Unchanged |
| 26 | MTEMEUR | Molecular Templates Inc | — | — | Unchanged |
| 27 | XCUREUR | Exicure Inc | — | — | Unchanged |
| 28 | SPWR | Sunpower Inc | 0% | +79.78% | Add |
| 29 | GDS | Gds Holdings LTD - Adr | -0.1% | — | Unchanged |
| 30 | ✓ | Effector Therapeutics Inc | -0.1% | EXIT | Sold out |
| 31 | SPRU | Spruce Power Holding Corporation | -0.3% | — | Unchanged |
| 32 | ✓ | Jasper Therapeutics Inc | -0.3% | EXIT | Sold out |
| 33 | VERA | Vera Therapeutics Inc | -1.1% | EXIT | Sold out |
| 34 | GTM | Zoominfo Technologies Inc | -4.8% | -25.54% | Trim |
| 35 | QDEL | Quidelortho CORP | -6.5% | — | Unchanged |
According to official SEC Form 13F filings, Carlyle Group Inc. reported a total U.S. public equity portfolio value of $10.0B across 32 disclosed positions in Q1 2024.
During Q1 2024, Carlyle Group Inc.'s top holdings by market value included QDEL (37.7%)、GTM (26.5%)、SLNOEUR (10.9%). The largest single position, QDEL, represented 37.7% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
JSPR
市值: $31.3M
Top Position Liquidated / Trimmed
VERA
前期市值: $22.1M
In Q1 2024, Carlyle Group Inc. made 18 total portfolio adjustments, initiating 10 new buys, adding to 3 positions, trimming 2 holdings, and fully liquidating 3 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.